SAGA Diagnostics

We are growing and looking for new team members to join our US based team. 🚀 - VP Medical Affairs - Remote US - Medical Science Liaison – Southwest, US - Controller - Morrisville, North Carolina Plus, many more open roles. If you are fueled by a passion to push the boundaries in oncology, then you could be just the person we’re looking for. For a list of all our open roles, more information and to apply > https://lnkd.in/e8HyNYaH

Are you heading to #AACR25? Our team will be there Peter Collins, Patrick Eimerman, Scott A. Shell, Ph.D and Jennifer Yen. At SAGA, we are redefining the standard for MRD detection and driving a new era of oncology patient care. Breaking barriers in clinical performance 🚀 Contact us to find out more 📧 See you there!

Today at World CB & CDx Summit Europe 🗓️ Patrick Eimerman, VP BD amd Partnering will be presenting at 11.50 ⏰ ‘Next-Gen MRD: Increasing Access to Ultrasensitive ctDNA Assessment for Biomarker Discovery, Development, and CDx Programs’ Hear the very latest from SAGA Diagnostics…. #mrd #oncology #biomarkers #ctDNA

A great day at the World CB & CDx Summit Europe in London today! Informative presentations and excellent networking 🚀 SAGA Diagnostics is revolutionizing the earlier detection of Molecular Residual Disease (MRD) to help inform personalized treatment. Find out more from our team onsite - Peter Collins, Patrick Eimerman and Samuel Woodhouse. #mrd #oncology #clinicaltrials #breastcancer

We are excited to be at World CB & CDx Summit Europe in London this week 🚀 Peter Collins, CEO and Patrick Eimerman, VP BD and Partnering will be attending. #diagnostics #MRD #oncology

Day two! We are thrilled to be at the St. Gallen Internstinal Breast Cancer Conference in beautiful Vienna, surrounded by inspiring minds and groundbreaking ideas. Another day of connecting, learning and innovating! 🚀 Karen Howarth Peter Collins

Our CEO Peter Collins and VP Clinical Development and Scientific Affairs Karen Howarth are attending the St.Gallen International Breast Cancer Conference in Vienna. Looking forward to an informative few days and meetings. See you there! #mrd #breastcancer

We are excited to be an official partner for the upcoming Liquid Biopsy for Precision Oncology Summit in San Diego, Feb 18-20. Our VP Business Development and Partnering Patrick Eimerman will be attending. Please contact Patrick if you would like to meet up. At SAGA, we are revolutionizing the early detection of Molecular Residual Disease (MRD) to help inform personalized treatment and improve outcomes.

On International Day of Women and Girls in Science we are thrilled to shine a light on three of our female leadership superstars. Karen Howarth, Karolina Holm and Annina E. Hube all share their thoughts for anyone looking at a career in science. We are proud to be driving innovation and making a real difference to the lives of people living with cancer. If you are fueled by a passion to push the boundaries in oncology, then you could be just the person we’re looking for to join our expanding team. Located in the heart of life science ecosystems in RTP, NC and Lund, Sweden, we’re looking to grow our team of talented and driven individuals. Our open roles are posted here https://lnkd.in/eFvsVJbm #stem #openroles

On #WorldCancerDay we are #UnitedByUnique. At SAGA we know that behind every sample we process is a unique human story - a personal story of sadness, grief, resilience and hope. We never lose sight of our guiding purpose to bring comfort, confidence and control to cancer therapy decision-making. This World Cancer Day let's all come together to rewrite the future of cancer care - one where the needs of people and communities always come first. Find out more about this year’s campaign here https://lnkd.in/drnuZeE